EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,000 | -75.0% | 1,547 | -55.4% | 0.00% | – |
Q4 2021 | $8,000 | -50.0% | 3,472 | +11.4% | 0.00% | – |
Q3 2021 | $16,000 | -15.8% | 3,117 | +36.3% | 0.00% | – |
Q2 2021 | $19,000 | +35.7% | 2,287 | +41.5% | 0.00% | – |
Q1 2021 | $14,000 | +7.7% | 1,616 | +43.6% | 0.00% | – |
Q4 2020 | $13,000 | -7.1% | 1,125 | 0.0% | 0.00% | – |
Q3 2020 | $14,000 | -41.7% | 1,125 | -43.8% | 0.00% | – |
Q4 2016 | $24,000 | +20.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $20,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $24,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $32,000 | +23.1% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $26,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
BP PLC | 24,687 | $28,000 | 0.16% |
NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |